7th March 2023
Advancing with end-to-end automation
Overview A virology contract research organisation (CRO) worked with Automata to take...
29th July 2022
Reducing human interaction in ELISA
How Automata worked with a UK-based CRO to reduce human steps and...
22nd February 2022
Flexible automation in drug discovery: an expert’s perspective
John Vincent, Senior Scientist at Medicines Discovery Catapult, discusses why flexible lab...
4th February 2022
Investigating lab automation in early drug discovery
Rapidly developing breakthrough treatments at pace is critical. We investigate the benefits...
21st January 2022
The benefits of automation in drug discovery: An expert’s perspective – Automata
We sit down with John Vincent, Senior Scientist at Medicines Discovery Catapult,...
